This Abbott Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

• Oppenheimer analyst Suraj Kalia initiated coverage on Abbott Laboratories ABT with an Outperform rating and announced a price target of $130. Abbott shares gained 0.6% to close at $113.36 on Monday. See how other analysts view this stock.
• Wells Fargo analyst Eva Fortea Verdejo initiated coverage on Arcus Biosciences, Inc. RCUS with an Overweight rating and announced a price target of $29. Arcus Biosciences shares gained 3.9% to close at $17.30 on Monday. See how other analysts view this stock.
• Susquehanna analyst Charles Minervino initiated coverage on Howmet Aerospace Inc. HWM with a Positive rating and announced a price target of $120. Howmet Aerospace shares gained 0.8% to close at $102.83 on Monday. See how other analysts view this stock.
• Morgan Stanley analyst Judah Frommer initiated coverage on Bicara Therapeutics Inc. BCAX with an Overweight rating and announced a price target of $35. Bicara Therapeutics shares fell 2.8% to close at $24.45 on Monday. See how other analysts view this stock.
• Hovde Group initiated coverage on First National Corporation FXNC with an Outperform rating and announced a price target of $22. First National shares gained 0.9% to close at $18.37 on Monday. See how other analysts view this stock.

Considering buying ABT stock? Here’s what analysts think:

Read More:

• Dow Dips Around 400 Points As Treasury Yields Top 4%: Investor Optimism Declines, But Fear Index Remains In ‘Greed’ Zone